Identity
- Trade Name
- Accelerate Pheno™ System FDA UDI
- Generic Name
- Multiple-type bloodstream pathogen nucleic acid IVD, kit, nucleic acid amplification/mass spectrometry FDA UDI
- Device Name
- The Accelerate Pheno™ system is a fully-integrated in vitro diagnostic system comprised of one to four module(s), a Control PC, Analysis PC(s), touchscreen monitor and Accelerate Pheno system software for use with Accelerate PhenoTest™ kits. It is designed to perform identification (ID) and quantitation of bacterial and yeast cells in less than 90 minutes and antimicrobial susceptibility testing (AST) on average in less than 7 hours directly from patient samples. Identification uses fluorescence in situ hybridization (FISH) and susceptibility testing uses microscopic observation of individual, live, growing bacterial cells in near real time (approximately every 10 minutes) in the presence of antimicrobial agents. FDA UDI
- Model / Reference
- 10401008 FDA UDI
- Description
- The Accelerate Pheno™ system is a fully-integrated in vitro diagnostic system comprised of one to four module(s), a Control PC, Analysis PC(s), touchscreen monitor and Accelerate Pheno system software for use with Accelerate PhenoTest™ kits. It is designed to perform identification (ID) and quantitation of bacterial and yeast cells in less than 90 minutes and antimicrobial susceptibility testing (AST) on average in less than 7 hours directly from patient samples. Identification uses fluorescence in situ hybridization (FISH) and susceptibility testing uses microscopic observation of individual, live, growing bacterial cells in near real time (approximately every 10 minutes) in the presence of antimicrobial agents. FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00862011000314 FDA UDI
- 510(k) Number
- DEN160032 FDA UDI
- FDA Product Code
- PRH FDA UDI
- GMDN Term
- Multiple-type bloodstream pathogen nucleic acid IVD, kit, nucleic acid amplification/mass spectrometry FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 866.1650 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Accelerate Pheno™ System by Accelerate Diagnostics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Multiple-type bloodstream pathogen nucleic acid IVD, kit, nucleic acid amplification/mass spectrometry.
- iC-GPC Assay — Icubate, Inc. · Class II
- ePlex — GenMark Diagnostics · Class II
- ePlex — GenMark Diagnostics · Class II
- BioFire® Blood Culture Identification 2 (BCID2) Panel — BioFire Diagnostics, LLC · Class II
- ePlex — GenMark Diagnostics · Class II
- ePlex — GenMark Diagnostics · Class II
- ePlex — GenMark Diagnostics · Class II
- ePlex — GenMark Diagnostics · Class II
Cleared under the same submission
DEN160032 also covers:
- Accelerate PhenoTest BC AST QC test — Accelerate Diagnostics, Inc.
- Accelerate PhenoTest BC ID QC test — Accelerate Diagnostics, Inc.
- Accelerate PhenoTest® BC AST QC test — Accelerate Diagnostics, Inc.
- Accelerate PhenoTest® BC kit — Accelerate Diagnostics, Inc.
- Accelerate PhenoTest™ BC Kit — Accelerate Diagnostics, Inc.
- Accelerate Pheno™ System — Accelerate Diagnostics, Inc.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Accelerate Diagnostics, Inc.
Sources (1)
- FDA UDI 06494a30-6dbe-4321-b7be-644dd2505cfd 34 fields · synced May 30, 2026